|
CDV3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.416070E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.679000E-03 |
| Normal-vs-Stage2 |
1.497730E-02 |
| Normal-vs-Stage3 |
3.9597999999974E-05 |
| Normal-vs-Stage4 |
1.340310E-02 |
| Stage1-vs-Stage2 |
4.354000E-01 |
| Stage1-vs-Stage3 |
1.659830E-02 |
| Stage1-vs-Stage4 |
6.572200E-01 |
| Stage2-vs-Stage3 |
5.507800E-01 |
| Stage2-vs-Stage4 |
7.154800E-01 |
| Stage3-vs-Stage4 |
2.161600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.020600E-04 |
| Normal-vs-AfricanAmerican |
1.202170E-03 |
| Normal-vs-Asian |
3.095200E-01 |
| Caucasian-vs-AfricanAmerican |
5.758600E-01 |
| Caucasian-vs-Asian |
7.954200E-01 |
| AfricanAmerican-vs-Asian |
5.976400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.69230999998993E-05 |
| Normal-vs-Female |
3.040400E-02 |
| Male-vs-Female |
1.202070E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.285700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.080300E-03 |
| Normal-vs-Age(61-80Yrs) |
3.974000E-04 |
| Normal-vs-Age(81-100Yrs) |
8.17680000000376E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.127400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.403400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.082800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.272600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.702200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.549900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.564200E-01 |
| Normal-vs-Grade 2 |
3.863100E-03 |
| Normal-vs-Grade 3 |
3.74060000000176E-05 |
| Normal-vs-Grade 4 |
2.427600E-02 |
| Grade 1-vs-Grade 2 |
2.735000E-01 |
| Grade 1-vs-Grade 3 |
1.261220E-01 |
| Grade 1-vs-Grade 4 |
3.693800E-01 |
| Grade 2-vs-Grade 3 |
9.752400E-02 |
| Grade 2-vs-Grade 4 |
8.039600E-01 |
| Grade 3-vs-Grade 4 |
4.692400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.217000E-03 |
| Normal-vs-ccB subtype |
2.584600E-03 |
| ccA subtype-vs-ccB subtype |
8.206800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.117290E-03 |
| Normal-vs-N1 |
9.868400E-01 |
| N0-vs-N1 |
3.226800E-01 |
|
|
